Absorption |
Blood-Brain Barrier | BBB+ | 0.9422 |
Human Intestinal Absorption | HIA+ | 0.9475 |
Caco-2 Permeability | Caco2- | 0.5951 |
P-glycoprotein Substrate | Substrate | 0.8508 |
P-glycoprotein Inhibitor | Inhibitor | 0.7335 |
Inhibitor | 0.8387 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8435 |
Distribution |
Subcellular localization | Mitochondria | 0.7384 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8350 |
CYP450 2D6 Substrate | Non-substrate | 0.9254 |
CYP450 3A4 Substrate | Substrate | 0.7513 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9307 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
CYP450 3A4 Inhibitor | Inhibitor | 0.7959 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8682 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8921 |
Non-inhibitor | 0.8573 |
AMES Toxicity | Non AMES toxic | 0.7920 |
Carcinogens | Non-carcinogens | 0.9408 |
Fish Toxicity | High FHMT | 0.9940 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9998 |
Honey Bee Toxicity | High HBT | 0.8586 |
Biodegradation | Not ready biodegradable | 0.9657 |
Acute Oral Toxicity | III | 0.7945 |
Carcinogenicity (Three-class) | Non-required | 0.7060 |